Skip to main content
Equibles
LXRX logo

LXRX · Lexicon Pharmaceuticals, Inc. · Short Interest

Track LXRX — free

Use LXRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LXRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.88 -0.01 (-0.27%) At close · Sep 30
Russell 2000 member Rebalance outlook locked
Market Cap
$798.70M
Shares
444.96M
Volume · Sep 30 1.74M Avg daily vol (3M) 2.96M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Pull short interest history through the short interest API or MCP →

LXRX Latest Reported Short Interest

FINRA reported 28,793,507 LXRX shares sold short as of the September 15, 2026 settlement date, a decrease of 697,302 shares. Days to cover was 13.40 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

LXRX Short Interest Forecast

Equibles' model estimates 29,041,960 shares sold short for the September 30, 2026 settlement, +0.9% versus the latest reported position, with a likely range of 26,217,234 to 31,785,895 shares. This model prediction uses FINRA data through September 30, 2026; FINRA's official release is expected October 9, 2026.

Model estimate

Expected Sep 30 short interest

as of Sep 30 Low confidence 57% chance it falls
29,041,960 +0.9% vs reported
Likely range 26,217,234 to 31,785,895 The latest estimate appears in the chart below. Official release expected Oct 9. Methodology
Short Squeeze Score
65/100
Short interest 6.5% of shares — P79 Days to cover 13.4 — P93 Price vs VWAP -15.4% — P21 Short-volume trend +3.0% — P59 Short interest change -2.4% — P34 Worst FTD 0.03% of shares — P68

Positioning score 64.6 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-15). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-01 05:20 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-10-15 Scheduled
    FINRA publishes Oct 26
    		 — — — —
    2026-09-30 Scheduled
    FINRA publishes Oct 9
    		 — — — —
    2026-09-15 28,793,507 29,490,809 -697,302 13.40
    2026-08-31 29,490,809 32,749,669 -3,258,860 10.28
    2026-08-14 32,749,669 32,825,365 -75,696 10.93
    2026-07-31 32,825,365 32,730,919 +94,446 12.46
    2026-07-15 32,730,919 30,784,601 +1,946,318 12.03
    2026-06-30 30,784,601 25,425,636 +5,358,965 4.44
    2026-06-15 25,425,636 26,206,147 -780,511 12.62
    2026-05-29 26,206,147 26,140,915 +65,232 13.74
    2026-05-15 26,140,915 23,857,393 +2,283,522 6.22
    2026-04-30 23,857,393 23,674,019 +183,374 13.59
    2026-04-15 23,674,019 22,932,295 +741,724 11.62
    2026-03-31 22,932,295 22,693,812 +238,483 9.07
    2026-03-13 22,693,812 23,139,559 -445,747 7.14
    2026-02-27 23,139,559 24,523,367 -1,383,808 12.65
    2026-02-13 24,523,367 24,583,755 -60,388 8.57
    2026-01-30 24,583,755 25,160,782 -577,027 4.69
    2026-01-15 25,160,782 23,660,410 +1,500,372 17.95
    2025-12-31 23,660,410 23,344,944 +315,466 12.34
    2025-12-15 23,344,944 24,226,907 -881,963 16.82
    2025-11-28 24,226,907 24,649,659 -422,752 16.97
    2025-11-14 24,649,659 27,704,594 -3,054,935 8.42
    2025-10-31 27,704,594 26,834,292 +870,302 16.50
    2025-10-15 26,834,292 27,299,898 -465,606 8.37

    Full FINRA short interest reporting calendar

    Showing 1–23 of 23 settlements
    Key facts CIK 1062822 CUSIP 528872302 13F (30d) 4 filings 4 filers Visit website Investor relations